Navigation Links
Preventing mental decline in the aged

According to a new study, it has been found that there are ways to keep your mental abilities sharp as you age. Mental decline is not a specific part of life. The older population is growing rapidly and people// are typically living longer. The ability to know, think, learn and judge, known as cognitive ability, is essential to quality of life and survival in older ages. Researchers from the Institute for the Study of Aging in New York looked at research that focuses on various lifestyle factors and medical conditions that affect seniors and their cognitive ability.

Researchers report most factors are potentially modifiable or manageable. For example, studies show that lifelong learning, mental and physical exercise, continuing social engagement, stress reduction, and proper nutrition may be important factors when it comes to cognitive vitality in the aging.

Another area that could help seniors keep their cognitive ability is therapeutic strategies. Researchers say antioxidants and anti-inflammatories may eventually prove useful in the prevention and treatment of cognitive decline in the aging.

The study also shows medical conditions such as diabetes, hypertension and hyperlipidemia, or excess fats in the blood, can contribute to mental decline in older people. Drinking too much alcohol or smoking may also promote cognitive decline and avoiding these activities could help an older person maintain cognitive ability.

Researchers conclude cognitive vitality is crucial to optimal aging. They say clear data is now beginning to show scientific basis for achieving and maintaining cognitive vitality in later life.


'"/>




Page: 1

Related medicine news :

1. Preventing white coat hypertension
2. Preventing Childhood Deaths
3. Preventing Vision Loss
4. Preventing Vision Loss
5. Preventing Colorectal Cancer
6. Preventing Prostate Cancer
7. Lycopene Can Help In Preventing Prostate Cancer
8. Heart Drug Also Effective In Preventing Specific Causes Of Death
9. Preventing cavities in children
10. Preventing Strokes Using Less Invasive Techniques
11. Preventing Bone Metastasis In Patients With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Preventing mental decline the aged

(Date:5/22/2008)... PHOENIX, May 22 /PRNewswire/ -- TriWest Heal...Telly Awards in the 28th Annual Telly Awards,compe...r the visual arts,community., The awards recogniz...ideo as an effective medium to reach military serv...sources and clinical support tools., "At TriWest,...
(Date:5/22/2008)... IRVINE, Calif., May 22 /PRNewswire/ -- Accen...een formally accepted into Sun,s Authorized,Subcon...Delivery Workforce,to provide improved integration...w relationship, Accenx Technologies will see subst...nt roster, develop a closer working,relationship w...
(Date:5/22/2008)... , LOS ANGELES, May 22 /PRNewswire-USNewswire/ -...used on prevention and recovery from Autism,ADHD ... of the organization,through three major steps:, ...ave joined the Board,of Directors., Ms. McCarthy ...other,who recovered her son Evan from autism. Her ...
(Date:5/22/2008)... First Product That Gives Consumers an All-Natura...robiotics & Prebiotic Fiber, JERICHO, N.Y., May 2...ottage cheese with more healthy benefits hits supe...e Health Cottage Cheese with Pro-Active,Nutrients....ed All-Natural,cottage cheese product, Friendship ...
Breaking Medicine News(10 mins):Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 2Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 3Health News:Accenx Technologies Joins Sun's Authorized Subcontractor Program 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 3
...Doctors at Indore surgically removed an arrowhead,...ago. Till the weapon was removed surgically the tr...nd normally as if nothing has happened. Gajuram, ...l 7 by an arrow by fellow tribesman Kaliya when he...
...Students in Haryana will get a chance to learn yog...ga in the government schools across// the state. ...he was keen to introduce the yoga classes from thi... attended Ramdev's yoga training camp at the indus...
...The years have not lessened the pain of losing the...red Ashok Trivedi and his wife Meenakshi to run fr...hildren are similarly afflicted. The Trivedis we...ed in 1997. They had tried their best to save her,...
...Researchers at Harvard Medical School have been ab...iphering the value that people attach// to differe...he nature of decision making, when a person needs ...le. To quote the words of Camillo Padoa-Schioppa,...
Other Medicine News:Health News:Distressed Couple Assists Parents Of Mentally Challenged Kids 2Health News:Decision-Making Enabled By Neurons: Value Assigned To Available Choices. 2
(Date:5/21/2008)...rom CHARM Study in Remission at One Year ...T PARK, Ill., May 21 /- Res...ott pivotal studies, CHARM and GAIN,demonstrate t...ted with,HUMIRA(R) (adalimumab) achieved long-term...ively, according to data presentations today at Di...
(Date:5/21/2008)...ighlight Watson,s commitment to urology - ..., Fla., May 21 /- Watson Ph...alty pharmaceutical company, announced,today that ... 3 products at,the American Urological Association... safety trial involving silodosin, an investigatio...
(Date:5/21/2008).../ -- Alba Therapeutics Corporation,announced today...presented,in the Clinical Advances in Celiac Disea...ting in San Diego, California. Results of the rand... larazotide acetate for the,prevention of celiac d...subjects in remission(1) were presented by Daniel ...
(Date:5/21/2008)...long-term survivors validate Jennerex ...SCO and YONGIN-SI, South Korea, May 21 /PRNewswire... Ontario), and its South,Korean partner Green Cros...al results from its first-in-class lead product JX...Oncology. The majority of these end- stage,patient...
Breaking Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 1Neurobiological Technologies Announces Pricing of Its 2460 Million Common Stock Offering 1579 2Younger Adults Increasingly Treated for Heart Disease related Conditions 694 1Younger Adults Increasingly Treated for Heart Disease related Conditions 694 2Younger Adults Increasingly Treated for Heart Disease related Conditions 694 3Younger Adults Increasingly Treated for Heart Disease related Conditions 694 4P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 1P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 2P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 3P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 4P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 5P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 6P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 7P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 8P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 9P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 10P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 11P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 12P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 13P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 14P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 15P 26G Reports EPS of 240 92 Up 16 25 Behind 8 25 Sales Growth 4952 16Elan Pharmaceuticals Inc Licenses Software and Databases From GeneGo 4948 1
... /PRNewswire-FirstCall/ --,Alfacell Corporation,s ...s a potent payload in antibody conjugates for canc... Handbook of Therapeutic,Antibodies. , In a chapte...ybak, Ph.D. summarizes preclinical research indica...improves in a number of tumor,models, including no...
...PRNewswire/ -- Treatment of,coronary artery diseas...ient setting, according to a study published today...pitalization rates for heart attacks (acute myocar...to 2005, possibly due,to broader use of preventive...ell as declines in risk factors like smoking. , Th...
Other Medicine Technology:Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3
...r transfusion needs. A recognized leader in autotr...ay to add the safety of microfiltration for a vari...ve or postoperative applications, autologous or ho...rovides both convenience and versatility in the re...
This high technology cast plaster cutter saw is very easy and comfortable to use.
Designed to reduce noise to a minimum results in less emotional trauma for patients and less hearing trauma for the clinician. The innovative motor plus saw design delivers high power in a smaller, l
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws.
Medicine Products: